Prelude Therapeutics (PRLD US)

Prelude Therapeutics Incorporated operates as a biopharmaceutical company. The Company develops and designs a pipeline of novel, orally bioavailable, and small molecule therapies that target key drivers of cancer cell growth. Prelude Therapeutics serves patients worldwide.